GBL
gamma-butyrolactone
1Provenance card
the boundary, as counts
Sources
3624 with DOI
18 strong · 6 moderate · 12 weak
Compilations
12026-05-09T03:16:40.291Z
pipeline-v5 · prompt hash not recorded — run predates 2026-09
Decisions
37last ruled 2026-10-02
1 awaiting a ruling
Issued documents
42026-10-02T13:08:43.714Z
notice · info card · emergency
Searches
281 with no results
queries and counts on the build
Claims checked
12775 supported
75 supported · 52 not
Correspondence
0received
consent field ships in Phase 4
Edges
383
derivations recorded for this entity
Complete over 36 sources, 1 compilation, and 37 decisions.Not here: the private journal (never); 1 proposal awaiting a ruling (listed as pending only).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/gbl/archive
Timeline
what happened, newest first — claims, searches and artifacts stay inside Build
- 2026-10-02issueIssued info_card
- 2026-10-02srcAcute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD)
- 2026-10-02srcGHB receptor targets in the CNS: focus on high-affinity binding sites
- 2026-10-02srcThe behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humans
- 2026-10-02srcComparative study of equimolar doses of gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4-BD) and gamma-butyrolactone (GBL) on catalepsy after acute and chronic administration
- 2026-10-02srcRegional Fos-expression induced by γ-hydroxybutyrate (GHB): comparison with γ-butyrolactone (GBL) and effects of co-administration of GABA-B antagonist
- 2026-10-02srcInternational Union of Basic and Clinical Pharmacology. CXX. γ-Hydroxybutyrate protein targets in the mammalian brain—beyond classic receptors
- 2026-10-02srcClinical relevance of ethanol coingestion in patients with GHB/GBL intoxication
- 2026-10-02srcGamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4BD), and gamma-butyrolactone (GBL) intoxication: A state-of-the-art review
- 2026-10-02srcWithdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: a case report and systematic review
- 2026-10-02srcGamma-butyrolactone withdrawal delirium with rhabdomyolysis and dialysis dependent renal failure
- 2026-10-02srcWithdrawal, recovery, and long-term sequelae of gamma-butyrolactone dependence: a case report
- 2026-10-02srcManagement and treatment of gamma butyrolactone withdrawal syndrome: a case report and review
- 2026-10-02srcIntoxications due to ingestion of gamma-butyrolactone: organ distribution of gamma-hydroxybutyric acid and gamma-butyrolactone
- 2026-10-02srcChems4EU: chemsex use and its impacts across four European countries in HIV-positive men who have sex with men attending HIV services
- 2026-10-02srcGamma-butyrolactone (GBL) dependence and withdrawal
- 2026-10-02srcEffects of monocarboxylate transporter inhibition on the oral toxicokinetics/toxicodynamics of GHB and GBL
- 2026-10-02srcThe Neurobiological Mechanisms of Gamma-Hydroxybutyrate Dependence and Withdrawal and Their Clinical Relevance: A Review
- 2026-10-02srcSimultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young men
- 2026-10-02srcOverview of the proton-coupled MCT (SLC16A) family of transporters and role in transport of GHB
- 2026-10-02srcThe first reported UK fatality related to gamma-butyrolactone (GBL) ingestion
- 2026-10-02srcDifferential Effects of GABA-B Receptor Subtypes, γ-Hydroxybutyric Acid, and Baclofen on EEG Activity and Sleep Regulation
- 2026-10-02srcGHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome
- 2026-10-02srcWhen Chems Meet Sex: A Rising Phenomenon Called ChemSex
- 2026-10-02srcThe clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol
- 2026-10-02srcSpecific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice
- 2026-10-02srcGamma-hydroxybutyrate and ethanol effects and interactions in humans
- 2026-10-02srcUrinary gamma-hydroxybutyrate concentrations in 1126 female subjects
- 2026-10-02srcUnusual presentation of a patient with GBL withdrawal: a case report
- 2026-10-02srcThe Use of GHB to Facilitate Sexual Assault
- 2026-10-02srcImproving GHB withdrawal with baclofen: study protocol for a feasibility study for a randomised controlled trial
- 2026-10-02srcPlacement of Gamma-Butyrolactone in List I of the Controlled Substances Act
- 2026-10-02srcGBL - gamma-Butyrolactone: DEA Drug/Chemical Information
- 2026-10-02srcGBL industrial uses and chemical properties (various chemical databases)
- 2026-10-02srcgamma-Butyrolactone (GBL): Chemical and Physical Properties
- 2026-10-02srcCircular 004/2022: GBL and 1,4-BD revocation of rescheduling
- 2026-10-02srcHenri Laborit and the synthesis of GHB (1960-1964)
- 2026-10-02publicationPublication — publishagent-psx
- 2026-10-02revisionr1.a1
- 2026-10-02rulingRuling — psx:substance/gbl/proposal/article_section_proposals/bf5948e7-5f20-4146-b7f8-c1906b9448c9founder
- 2026-10-02rulingRuling — psx:substance/gbl/proposal/article_section_proposals/cb69b110-2e61-431e-bf77-243e88c5bdb0founder
- 2026-09-04issueIssued emergency
- 2026-09-04issueIssued info_card
- 2026-09-04issueIssued notice
- 2026-07-03proposaldependence · taper
- 2026-06-04proposal30 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
- 2026-06-04publicationPublication — backfill
- 2026-05-09revisionRevision 1
- 2026-05-09absenceSearched ClinicalTrials.gov for "gamma-butyrolactone GBL" — no results
- 2026-05-09genGeneration — pipeline-v5 · with 3 morepipeline-v5
- 2026-05-09rungeneration run
The same entries, as forms: six forms.